Charu Aggarwal
Papers
9
Total Citations
329
H-Index
6
About
Charu Aggarwal is a leading clinical researcher in head and neck oncology, with a focused expertise in human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma. Her work centers on optimizing treatment de-intensification strategies, particularly through the use of transoral robotic surgery (TORS) and advanced radiation techniques. Aggarwal’s major contributions include landmark studies on omitting the primary tumor bed during radiation (the AVOID trial, 167 citations) and demonstrating superior quality-of-life outcomes with proton therapy versus conventional photon radiation. She has also established critical benchmarks for oncologic outcomes and lethal recurrence risk after TORS, and has shown that older patients can safely undergo surgery without compromising survival. Her research on recurrence patterns and salvage rates in patients who forgo recommended adjuvant therapy (33 citations) provides vital guidance for clinical decision-making. With over 300 cumulative citations across her most influential papers, Aggarwal’s work has shaped modern, less-toxic treatment paradigms for HPV-positive oropharyngeal cancer, making her a key figure in the movement toward personalized, function-preserving head and neck cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9